Abstract: Aggressive periodontitis is a relatively rare periodontal condition that can result in significant attachment loss over a short period of time. As the disease is difficult to manage, owing to its rapid progression and severity, a variety of adjuncts have been advocated in its management. The authors outline concepts of the aetiology and pathogenesis of aggressive periodontitis and how the different treatment regimens relate to the current understanding of the disease process. Clinical Relevance: There is a wide variety of treatment regimens advocated for the treatment of aggressive periodontitis. General dental practitioners and specialists should be aware of the relative advantages and disadvantages of these and how they relate to the disease process. Dent Update 2011; 38: 511-521
October 2011 can be further classified as localized or generalized (Table 1) (Figures 1-4) . The localized form usually occurs around puberty and often affects first molars and then central incisors, although it is not always exclusive to these teeth.
Features of the generalized form include:
An occurrence below the age of 30 years;
Generalized interproximal bone loss affecting at least three permanent teeth other than the first molars and incisors;
A clear episodic nature of periodontal attachment loss; and A poor serum antibody response to infecting agents. [3] [4] [5] [6] Although these two subdivisions may have some substance in their criteria, the differences between localized and generalized may not be so obvious. The prevalence of AP varies according to the population studied and ranges from 0.1% in Caucasians to up to 22% in AfroCaribbeans. 7, 8 The aim of this paper is to investigate how our understanding of the aetiology of AP has influenced treatment options and outcomes.
Aetiology of aggressive periodontitis
There has been considerable research into the role of Aa in the aetiology of AP and this has had a significant impact upon treatment. Aggregatibacter actinomycetemcomitans possesses a large number of virulence factors which may be relevant in the pathogenesis of AP. These factors are shown in Table 2 .
In addition to such virulence factors, there is also a body of evidence to suggest that Aa can 'invade' the gingival October 2011 tissues. 9 The initial adhesion of Aa to the tooth surface and epithelial cells is mediated by fimbriae. Subsequent invasion may be mediated by adhesins and micro-vesicle formation, which will enable Aa to inhabit a variety of environments. This ability to invade and attach allows Aa to colonize and multiply within tissues, possibly making this species less susceptible to removal by mechanical instrumentation during root surface debridement.
Aetiology of AP and treatment options
The association between Aa and AP has led to extensive investigations into the efficacy of antibiotics in the management of this condition. In most instances, the antibiotics have been prescribed as adjuncts to either a surgical or non-surgical approach. Other treatment options that have recently been evaluated in the management of AP include:
Antimicrobial photodynamic therapy; Nd:YAG laser treatment; and A systemic 7-day course of etoricoxib, a COX-2 inhibitor. 10, 11, 12 These studies will be commented upon later.
Efficacy of adjunctive systemic antibiotics in the management of AP
A synopsis of the various studies that have evaluated the efficacy of adjunctive antibiotics in the management of AP is shown in Table 3 . [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] For the most part, the antibiotics have been used as an adjunct to a non-surgical approach for the underlying periodontal condition. The number of patients recruited into such studies have, of necessity, been small. AP is a relatively rare condition and this is reflected in the number of patients that have been evaluated. The follow-up period is likewise variable, and ranges from 6 to 18 months. The latter would be an exceptional timeframe for most periodontal studies of similar design. The antibiotics evaluated include tetracyclines, clindamycin, amoxicillin, metronidazole (also used in combination) and azithromycin. Outcome measures have mainly emphasized the reduction of probing pocket depths, although one study primarily focused on suppression of Aa. 25 It is clear from the outcomes of the various studies reported in Table 3 , that the benefits of systemic, adjunctive antibiotics in the management of AP is equivocal. The combination of amoxicillin and metronidazole does appear to be the most efficacious in this regard. By contrast, systemic tetracycline may have little value over the conventional nonsurgical approach.
Issues that can affect the efficacy of systemic antibiotics in the management of AP include timing of the course of antibiotics and compliance. Both issues have been evaluated. 17 Timing options for the prescription of systemic antibiotics could be immediately prior to the non-surgical root surface instrumentation (RSI), immediately after the debridement, or up to 3 months post-treatment. Prescribing immediately after RSI has been compared with taking a course of antibiotics 3 months after treatment. 17 The antibiotic used in this study was the amoxicillin/metronidazole combination. The authors showed that prescribing this combination after RSI was of greater benefit, in terms of probing pocket depth reduction, than the 3 month prescription.
Compliance with any antibiotic regimen is also an important factor that can affect efficacy of these drugs as adjunctive agents in the management of AP. 15 Poor compliance will result in fluctuating blood levels which will impact upon the bactericidal capacity of the antibiotics. Indeed, patients with good compliance show greater reduction in probing depths for sites >7mm.
The metronidazole/amoxicillin combination does appear to be the most widely investigated adjunctive antimicrobial regimen in the management of AP. Data from Table 3 suggest that the additional benefits of this combination results in a further 0.5-1.00mm additional mean reduction in probing pocket depth, when compared to a nonsurgical approach alone. This will approximate to an additional 20-25% benefit. Other periodontal parameters have been evaluated in the various clinical trials and these are reported in Table 3 .
The apparent periodontal benefits of the combination of amoxicillin and metronidazole need to be balanced against adverse effects arising from either agent. Of particular concern is the development of bacterial resistance and gastrointestinal disturbances. Duration of the course for this combination in the periodontal perspective is in the range of 7-10 days, and the longer the patient is exposed to the drugs, the greater the risk of adverse effects. In the studies cited in Table 3 , adverse events were recorded in some of the investigations. Further to these immediate complications, the long-term development of antibiotic resistance by periodontal pathogens has been reported. 26 In this study, patients who had used antibiotics within the previous year demonstrated antibiotic resistance in particular against metronidazole. 26 
Other adjuncts used in the management of aggressive periodontitis
Laser therapy using the Nd:YAG laser has been compared with a conventional Periodontology surgical approach in the management of AP.
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A split mouth design was used in this study and the results showed no difference between treatments with respect to periodontal outcomes. The authors suggested that the use of the Nd:YAG laser could be more useful for those patients who have disorders of haemostasis or anxiety about having surgery. The Nd:YAG laser has a significant antibacterial action and this may contribute towards its efficacy in the management of AP.
The antimicrobial properties of the laser have also been compared with conventional non-surgical management in patients with AP. 10 This study used a split mouth design and, at a 3-month evaluation, there were no differences between the treatments in relation to a variety of periodontal parameters.
Irrespective of the pathogenesis of AP, there is still, in most patients, a significant inflammatory component within the periodontal tissues which RSI alone can dramatically reduce (Figures 5 a, b) . Non-steroidal antiinflammatory drugs (NSAIDs) have been used as adjuncts in the management of chronic periodontitis. 27, 28 The adjunctive benefits of these drugs is somewhat limited in terms of reducing periodontal measures. 28 Animal models have shown that COX-2 inhibitors have the potential to reduce the inflammatory component of periodontal disease. 29 A clinical trial in patients with chronic periodontitis also indicated that the adjunctive use of a COX-2 inhibitor (loxoprofen) provided additional benefits in reducing deep periodontal pockets (>7 mm) over root surface instrumentation alone. 30 In contrast to this finding, when the COX-2 inhibitor (etoricoxib) was used as an adjunct to non-surgical management in patients with AP, no additional clinical benefits were found. 12 This finding may reflect the nature of AP, especially the possible limited role of plaque-induced inflammation in its pathogenesis.
Surgical management of AP
Interest in a surgical approach for the management of AP has arisen following the evidence that the gingival tissues may be invaded by Aa and other periodontopathogens. 9 Many of the surgical studies were completed in the 1980s and 90s and often involved only a small number of patients with a limited period of follow-up. In brief, studies have shown that AP can be managed by a surgical approach with or without adjunctive use of systemic antibiotics. For the most part, the adjunctive antibiotics used were tetracyclines. The evidence to support the adjunctive use of these drugs for this purpose is equivocal. Two studies have demonstrated that systemic tertacyclines enhance the surgical approach for the management of AP, whilst a further report showed little or no adjunctive benefit from doxycycline over open flap debridement. 31, 32, 33 There do not appear to be any recent studies comparing the surgical approach with the non-surgical approach for patients with AP.
Regenerative techniques
The periodontal defects associated with AP are often suitable for regenerative procedures. Furthermore, the distribution of such defects also affords the opportunity of evaluating different techniques in the same patient (the so-called split mouth design).
An early study compared guided tissue regeneration (GTR) with osseous surgery in 15 patients exhibiting paired defects. These patients were followed up for 12 months and those defects treated with GTR showed a significantly greater (p < 0.05) reduction in probing pocket depth and more attachment gain than those sites treated by osseous surgery. Radiographs also showed greater osseous infill at 12 months in the GTR treated sites. 34 Whilst there is a variety of GTR techniques available, there may be a lack of information on the best technique in certain defects. A four-way split mouth study compared surgical debridement alone with expanded polytetrafluoroethylene (ePTFE) membrane alone, ePTFE membrane with root conditioning with doxycycline, and ePTFE membrane with root conditioning and composite graft comprising calcium sulphate, DFDBA and doxycycline. All four techniques were evaluated in seven patients and followed October 2011
up for a period of 18 months. All four methods of treating such defects in AP patients resulted in a significant gain in attachment as well as an increase in volumetric bone fill, however, there was no difference between the various treatment options. 35 A more recent study has investigated the value of resorbable membranes and bioactive glass in the management of periodontal defects in patients with AP. 36 A total of 22 defects were treated with the membrane and 20 with the bioactive glass. Patients were followed up for five years. Both techniques provided significant reductions in probing pocket depths and attachment gain. Radiographs showed that there was greater bony infill in the bioactive glass-treated sites.
There is increasing evidence that regenerative techniques are a suitable option for the management of periodontal defects associated with AP. Although only a few studies have been reported, the evidence to date does show that these techniques afford advantages over conventional flap debridement. The outcome of studies so far suggests that the use of regenerative techniques for the management of AP warrants further investigation.
Supportive care
Two studies have reported on the long-term follow-up of patients with AP who have been treated by different approaches. In the first of these investigations, 13 patients with a diagnosis of AP were reviewed five years after treatment and the provision of supportive care. All patients had initially received a combination of mechanical, surgical and antimicrobial treatments. The patients were enrolled on a regularly scheduled maintenance programme. During the first year, subjects were monitored in 3-6 month recall intervals, which included repeat of oral hygiene instruction and full mouth prophylaxis. At 3 months post-treatment, clinical attachment levels reduced on average by 2.23 mm. At the 5 year review, only 3.2% of the sites in these patients showed further attachment loss >3 mm. The authors reported that periodontal disease progression was arrested in 95% of sites, which emphasizes the importance of providing patients with AP with a regular maintenance programme. 37 Where the prognosis of teeth is hopeless, with the possibility of spontaneous exfoliation, the decision to extract electively and replace such teeth may need to be considered ( Figure 6 ). 38 In cases where the disease is localized, the utilization of resinretained bridgework can be considered, particularly if the canine teeth can provide suitable abutments (Figure 7 ).
Conclusions
Aggressive periodontitis is a comparatively rare condition and its management is challenging. The link between specific bacteria and disease expression does seem to drive treatment options. In recent times, the non-surgical approach with adjunctive use of systemic antibiotics is to be the preferred treatment option. There is evidence that the amoxicillin/metronidazole combination provides additional benefit to non-surgical management. Surgery does have a role in the treatment of AP, but there is no consensus view with regard to the adjunctive use of systemic antibiotics for this approach. Regenerative techniques are certainly applicable for the management of AP and the choice of procedure would be dependent upon the nature of the defect. Finally, the provision of regular supportive care for all patients diagnosed and treated for AP is important. Maintenance programmes do have a value in preventing disease recurrence. 
